Details for Patent: 7,989,448
✉ Email this page to a colleague
Which drugs does patent 7,989,448 protect, and when does it expire?
Patent 7,989,448 protects TAVALISSE and is included in one NDA.
This patent has thirty-eight patent family members in twenty-nine countries.
Summary for Patent: 7,989,448
| Title: | Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| Abstract: | The present disclosure provides compounds of the following formula, ##STR00001## and methods of using the compounds to inhibit cellular degranulation and to treat diseases associated therewith. |
| Inventor(s): | Singh; Rajinder (Belmont, CA), Bhamidipati; Somasekhar (Foster City, CA), Masuda; Esteban (Menlo Park, CA) |
| Assignee: | Rigel Pharmaceuticals, Inc. (South San Francisco, CA) |
| Application Number: | 12/268,218 |
|
Patent Claim Types: see list of patent claims | Use; Compound; |
Drugs Protected by US Patent 7,989,448
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rigel Pharms | TAVALISSE | fostamatinib disodium | TABLET;ORAL | 209299-001 | Apr 17, 2018 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF THROMBOCYTOPENIA IN ADULT PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) WHO HAVE HAD AN INSUFFICIENT RESPONSE TO A PREVIOUS TREATMENT | ⤷ Sign Up | |||
| Rigel Pharms | TAVALISSE | fostamatinib disodium | TABLET;ORAL | 209299-002 | Apr 17, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF THROMBOCYTOPENIA IN ADULT PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) WHO HAVE HAD AN INSUFFICIENT RESPONSE TO A PREVIOUS TREATMENT | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,989,448
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1856135 | ⤷ Sign Up | 301039 | Netherlands | ⤷ Sign Up |
| European Patent Office | 1856135 | ⤷ Sign Up | CA 2020 00018 | Denmark | ⤷ Sign Up |
| European Patent Office | 1856135 | ⤷ Sign Up | LUC00153 | Luxembourg | ⤷ Sign Up |
| European Patent Office | 1856135 | ⤷ Sign Up | 122020000021 | Germany | ⤷ Sign Up |
| European Patent Office | 1856135 | ⤷ Sign Up | PA2020507 | Lithuania | ⤷ Sign Up |
| European Patent Office | 1856135 | ⤷ Sign Up | 132020000000046 | Italy | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
